Cellectis S.A.Cellectis S.A.Cellectis S.A.

Cellectis S.A.

No trades
Buy CLLS
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪136.14 M‬USD
−1.11USD
‪−101.06 M‬USD
‪755.00 K‬USD
‪69.26 M‬
Beta (1Y)
7.32

About CELLECTIS


CEO
André Choulika
Headquarters
Paris
Founded
1999
FIGI
BBG0084L1XN2
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.